ID24520A - Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya - Google Patents

Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya

Info

Publication number
ID24520A
ID24520A IDW991505A ID991505A ID24520A ID 24520 A ID24520 A ID 24520A ID W991505 A IDW991505 A ID W991505A ID 991505 A ID991505 A ID 991505A ID 24520 A ID24520 A ID 24520A
Authority
ID
Indonesia
Prior art keywords
yamg
analoges
analogue
peptides
pharmacy composition
Prior art date
Application number
IDW991505A
Other languages
English (en)
Indonesian (id)
Inventor
Delansorne Remi
Paris Jacques
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of ID24520A publication Critical patent/ID24520A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW991505A 1997-06-02 1998-05-06 Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya ID24520A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97401212A EP0882736A1 (en) 1997-06-02 1997-06-02 LH-RH peptide analogues, their uses and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ID24520A true ID24520A (id) 2000-07-20

Family

ID=8229769

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991505A ID24520A (id) 1997-06-02 1998-05-06 Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya

Country Status (38)

Country Link
US (1) US6586402B1 (cs)
EP (2) EP0882736A1 (cs)
JP (1) JP4346115B2 (cs)
KR (1) KR100582510B1 (cs)
CN (1) CN1134450C (cs)
AP (1) AP1195A (cs)
AR (1) AR011734A1 (cs)
AT (1) ATE204297T1 (cs)
AU (1) AU746132B2 (cs)
BR (1) BR9809910A (cs)
CA (1) CA2292846C (cs)
CO (1) CO4790174A1 (cs)
CZ (1) CZ299308B6 (cs)
DE (1) DE69801369T2 (cs)
DK (1) DK0984982T3 (cs)
DZ (1) DZ2509A1 (cs)
EE (1) EE03879B1 (cs)
ES (1) ES2166166T3 (cs)
HK (1) HK1029124A1 (cs)
HU (1) HUP0003592A3 (cs)
ID (1) ID24520A (cs)
IL (1) IL133210A0 (cs)
JO (1) JO2034B1 (cs)
MA (1) MA26502A1 (cs)
MY (1) MY122262A (cs)
NO (1) NO321786B1 (cs)
NZ (1) NZ501463A (cs)
OA (1) OA11305A (cs)
PE (1) PE84999A1 (cs)
PL (1) PL195474B1 (cs)
PT (1) PT984982E (cs)
RU (1) RU2212247C2 (cs)
SI (1) SI0984982T1 (cs)
TN (1) TNSN98075A1 (cs)
TR (1) TR199902997T2 (cs)
TW (1) TW479062B (cs)
WO (1) WO1998055505A1 (cs)
ZA (1) ZA983992B (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
US20020071829A1 (en) * 1999-04-15 2002-06-13 Richard Boyd Normalization of defective T cell responsiveness through manipulation of thymic regeneration
EP1345574A4 (en) * 2000-10-13 2006-05-31 Univ Monash IMPROVING ACCEPTANCE OF TRANSPLANTS BY CONTROLLING THYME REGENERATION
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
DE102004033902A1 (de) * 2004-07-14 2006-02-16 Zentaris Gmbh Neue Tetrahydrocarbazolderivate mit verbesserter biologischer Wirkung und verbesserter Löslichkeit als Liganden für G-Protein gekoppelte Rezeptoren (GPCR's)
NZ595303A (en) 2005-12-14 2013-03-28 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
CN102675418B (zh) * 2011-03-15 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物、其制备方法及用途
US20150079623A1 (en) * 2012-03-18 2015-03-19 Kyushu University, National University Corporation Apparatus, system and method for analyzing disease sample
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9393264B2 (en) * 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9849160B2 (en) * 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途
CN114014913B (zh) * 2022-01-10 2022-03-29 浙江湃肽生物有限公司南京分公司 醋酸曲普瑞林的纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NL7505590A (nl) * 1974-05-18 1975-11-20 Hoechst Ag Werkwijze voor het bereiden van peptiden met lh-rh/fsh-rh-werking.
DE2424287A1 (de) * 1974-05-18 1975-12-04 Hoechst Ag Peptide mit lh-rh/fsh-rh-wirkung und verfahren zu ihrer herstellung
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US5003011A (en) * 1985-04-09 1991-03-26 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
DE68928278T2 (de) * 1988-02-10 1998-03-12 Tap Pharmaceuticals Inc Lhrh-analog
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US6586402B1 (en) 2003-07-01
PL195474B1 (pl) 2007-09-28
EE9900546A (et) 2000-06-15
DZ2509A1 (fr) 2003-01-25
CA2292846A1 (en) 1998-12-10
ATE204297T1 (de) 2001-09-15
JO2034B1 (en) 1999-05-15
AR011734A1 (es) 2000-08-30
RU2212247C2 (ru) 2003-09-20
AP9901702A0 (en) 1999-12-31
AP1195A (en) 2003-08-18
JP4346115B2 (ja) 2009-10-21
EP0984982A1 (en) 2000-03-15
CO4790174A1 (es) 1999-05-31
ZA983992B (en) 1998-11-20
MA26502A1 (fr) 2004-12-20
TR199902997T2 (xx) 2000-03-21
PL337235A1 (en) 2000-08-14
HUP0003592A3 (en) 2001-05-28
ES2166166T3 (es) 2002-04-01
HUP0003592A2 (hu) 2001-02-28
TNSN98075A1 (fr) 2005-03-15
NO321786B1 (no) 2006-07-03
OA11305A (en) 2003-08-25
NO995891D0 (no) 1999-12-01
DE69801369T2 (de) 2002-05-16
AU7654198A (en) 1998-12-21
CZ299308B6 (cs) 2008-06-11
CA2292846C (en) 2009-12-08
PE84999A1 (es) 1999-09-15
HK1029124A1 (en) 2001-03-23
AU746132B2 (en) 2002-04-18
CZ432999A3 (cs) 2000-06-14
CN1263535A (zh) 2000-08-16
KR100582510B1 (ko) 2006-05-23
BR9809910A (pt) 2000-08-01
TW479062B (en) 2002-03-11
IL133210A0 (en) 2001-03-19
EP0984982B1 (en) 2001-08-16
EP0882736A1 (en) 1998-12-09
EE03879B1 (et) 2002-10-15
DK0984982T3 (da) 2001-11-12
MY122262A (en) 2006-04-29
CN1134450C (zh) 2004-01-14
JP2002502396A (ja) 2002-01-22
WO1998055505A1 (en) 1998-12-10
NO995891L (no) 2000-02-01
DE69801369D1 (de) 2001-09-20
SI0984982T1 (en) 2002-02-28
NZ501463A (en) 2001-07-27
KR20010013286A (ko) 2001-02-26
PT984982E (pt) 2002-02-28

Similar Documents

Publication Publication Date Title
ID24520A (id) Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya
ID24476A (id) Arilsulfonamida dan analognya
ID25543A (id) Alpha-aril-n-alkinitron dan komposisi farmasi yang mengandungnya
ID25528A (id) Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya
ID23439A (id) Turunan-turunan 3-piperidil-4-oksokuinazolin dan komposisi-komposisi farmasi yang sama
ID28846A (id) 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
ID24703A (id) Kuinolon antimikroba, komposisi dan penggunaannya
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
CY2013008I1 (el) Πεπτιδιο κατασταλτικο της ορεξης, συνθεσεις και χρηση αυτου
ID21019A (id) Turunan pirazol, pembuatannya dan penggunaannya dalam sediaan farmasi
HUP0100100A3 (en) Hepatitis c inhibitor peptide analogues, pharmaceutical compositions comprising thereof and their use
ATE285788T1 (de) Aktiviertes protein c formulierungen
NO20003254D0 (no) Anti-østrogene steroider og farmasøytisk preparat inneholdende samme, samt anvendelse derav
ID28270A (id) Komposisi dan formulasi peptida dan penggunaannya
NL300295I1 (nl) 3,3-Diarylpropylaminen, de toepassing en bereiding hiervan
FI973475A (fi) Koostumus ja sitä sisältävä tuote
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
ID28182A (id) Komposisi pewarna rambut dan penggunaannya
TR199800631A3 (tr) Ecza formülasyonu.
DE69830372D1 (de) Gaserzeugende zusammensetzung und formmasse davon
ID24196A (id) Komposisi dan penggunaan
ID29052A (id) Turunan-turunan 3,3-biarilpiperidina dan 2,2-biarilmorfolina
ID22660A (id) Turunan-turunan piridina dan komposisi farmasi yang mengandungnya
DE69831223D1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
ID27976A (id) 4,5,6 dan 7-indol dan turunan-turunan indolin, pembuatan dan penggunaannya